The emerging arrival of this new formulation represents a seemingly significant advancement in the handling of type 2 diabetes . This drug builds upon the prior success of lower dosages , showing impressive results in lowering blood glycemic control and supporting a decrease in weight. Researchers are exploring its overall benefit on heart outcomes